Literature DB >> 3433236

Impaired tracheobronchial clearance in bronchiectasis.

D C Currie1, D Pavia, J E Agnew, M T Lopez-Vidriero, P D Diamond, P J Cole, S W Clarke.   

Abstract

Tracheobronchial clearance was measured by a radioaerosol technique in 12 patients with bronchiectasis, seven patients with chronic obstructive lung disease expectorating mucoid sputum daily (group X), eight patients with chronic obstructive lung disease but negligible sputum expectoration (group Y), and 10 healthy subjects. The patients with bronchiectasis all expectorated purulent sputum daily (mean wet weight 47 g/day), had reduced forced expiratory volume in one second (FEV1) (mean 47.5% predicted), and were unable to avoid coughing during the six hour observation period. None of the patients with bronchiectasis or the healthy subjects were current smokers. There were five current smokers in group X and six in group Y. The mean FEV1 in group X was 41% predicted and in group Y 52% predicted, both values similar to that of the patients with bronchiectasis. Tracheobronchial clearance in the first six hours after inhalation of radioaerosol was significantly (p less than 0.01) slower in patients with bronchiectasis than in matched healthy subjects despite more proximal deposition of radioaerosol (p = 0.01) and more coughing (p less than 0.01) in the former. Tracheobronchial clearance in patients with bronchiectasis was impaired to a similar degree to that in patients with chronic obstructive lung disease but no bronchiectasis.

Entities:  

Mesh:

Year:  1987        PMID: 3433236      PMCID: PMC460641          DOI: 10.1136/thx.42.2.126

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  Aerosol penetrance: a sensitive index of peripheral airways obstruction.

Authors:  M B Dolovich; J Sanchis; C Rossman; M T Newhouse
Journal:  J Appl Physiol       Date:  1976-03       Impact factor: 3.531

2.  Particle penetration and clearance in the human lung. Results in healthy subjects and subjects with chronic bronchitis.

Authors:  M L Thomson; D Pavia
Journal:  Arch Environ Health       Date:  1974-10

3.  Mucociliary function in health, chronic obstructive airway disease, and asbestosis.

Authors:  M L Thomson; M D Short
Journal:  J Appl Physiol       Date:  1969-05       Impact factor: 3.531

4.  Techniques for measuring lung mucociliary clearance.

Authors:  D Pavia; J R Bateman; N F Sheahan; J E Agnew; S P Newman; S W Clarke
Journal:  Eur J Respir Dis Suppl       Date:  1980

5.  Mucociliary transport and ultrastructural abnormalities in Polynesian bronchiectasis.

Authors:  D A Waite; S J Wakefield; J B Mackay; I T Ross
Journal:  Chest       Date:  1981-12       Impact factor: 9.410

6.  Effect of lung function and mode of inhalation on penetration of aerosol into the human lung.

Authors:  D Pavia; M L Thomson; S W Clarke; H S Shannon
Journal:  Thorax       Date:  1977-04       Impact factor: 9.139

7.  Beat frequency of cilia from sites of purulent infection.

Authors:  R Wilson; D A Sykes; D Currie; P J Cole
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

8.  Immotile cilia syndrome in persons with and without Kartagener's syndrome.

Authors:  C M Rossman; J B Forrest; R E Ruffin; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1980-06

9.  On the pathogenesis of obstructive lung disease. A study on the immotile-cilia syndrome.

Authors:  B Mossberg; B A Afzelius; R Eliasson; P Camner
Journal:  Scand J Respir Dis       Date:  1978-04

10.  Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity.

Authors:  H Tegner; K Ohlsson; N G Toremalm; C von Mecklenburg
Journal:  Rhinology       Date:  1979-09       Impact factor: 3.681

View more
  10 in total

Review 1.  Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.

Authors:  Jonathan Ilowite; Peter Spiegler; Heather Kessler
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 2.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

3.  Effect of temazepam on tracheobronchial mucus clearance.

Authors:  A Hasani; M A Spiteri; D Pavia; M T Lopez-Vidriero; J E Agnew; S W Clarke
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

4.  Indium-111 labelled granulocyte scanning to detect inflammation in the lungs of patients with chronic sputum expectoration.

Authors:  D C Currie; A M Peters; N D Garbett; P George; B Strickland; J P Lavender; P J Cole
Journal:  Thorax       Date:  1990-07       Impact factor: 9.139

5.  Effect of oral bronchodilators on lung mucociliary clearance during sleep in patients with asthma.

Authors:  A Hasani; J E Agnew; D Pavia; H Vora; S W Clarke
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

6.  Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.

Authors:  R Amitani; G Taylor; E N Elezis; C Llewellyn-Jones; J Mitchell; F Kuze; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis.

Authors:  M Gaga; A M Bentley; M Humbert; J Barkans; F O'Brien; C G Wathen; A B Kay; S R Durham
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

Review 8.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

9.  The immune response and its therapeutic modulation in bronchiectasis.

Authors:  Massoud Daheshia; James D Prahl; Jacob J Carmichael; John S Parrish; Gilbert Seda
Journal:  Pulm Med       Date:  2012-10-10

Review 10.  Lung microbiology and exacerbations in COPD.

Authors:  Victoria Beasley; Priya V Joshi; Aran Singanayagam; Philip L Molyneaux; Sebastian L Johnston; Patrick Mallia
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.